NICE guidance released
- ABP
- May 12, 2024
- 1 min read
NICE have now approved Oncotype DX testing for node positive postmenopausal women.
For the full updated guidance, refer to the NICE website.
top of page
bottom of page
NICE have now approved Oncotype DX testing for node positive postmenopausal women.
For the full updated guidance, refer to the NICE website.
ความคิดเห็น